Authors:
King, MC
Wieand, S
Hale, K
Lee, M
Walsh, T
Owens, K
Tait, J
Ford, L
Dunn, BK
Costantino, J
Wickerham, L
Wolmark, N
Fisher, B
Citation: Mc. King et al., Tamoxifen and breast cancer incidence among women with inherited mutationsin BRCA1 and BRCA2 - National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial, J AM MED A, 286(18), 2001, pp. 2251-2256
Citation: B. Emir et al., Comparison of diagnostic markers with repeated measurements: a non-parametric ROC curve approach, STAT MED, 19(4), 2000, pp. 511-523
Authors:
Mamounas, E
Wieand, S
Wolmark, N
Bear, HD
Atkins, JN
Song, K
Jones, J
Rockette, H
Citation: E. Mamounas et al., Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' c colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04), J CL ONCOL, 17(5), 1999, pp. 1349-1355
Authors:
Wolmark, N
Rockette, H
Mamounas, E
Jones, J
Wieand, S
Wickerham, DL
Bear, HD
Atkins, JN
Dimitrov, NV
Glass, AG
Fisher, ER
Fisher, B
Citation: N. Wolmark et al., Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from national surgical adjuvant breast and bowel project C-04, J CL ONCOL, 17(11), 1999, pp. 3553-3559